Antitumor agent-92

Antitumor Agent-92, a derivative of Icaritin, is a promising small molecule for hepatocellular carcinoma (HCC) research. It induces G0/G1 phase cell cycle arrest and promotes apoptosis in vitro, showing potential for both cellular mechanism studies and in vivo therapeutic efficacy investigations.